Amador Bioscience is Laboratory Services (Healthcare) in China that focus on consulting services business. Founded in 2018. They cover business area such as provider, clinical laboratory, medical consulting service, pharmaceutical company, nonclinical/clinical study, consult service, clinical pharmacology, medicine validation, regulatory submission.
Laboratory Services (Healthcare)
2018
( 6 years old in 2024 )
Consulting Services
-
Unit 504-506, Building 1, Singapore Science & Technology Park
Jianggan District
Hangzhou, Zhejiang
China
Private
providerclinical laboratorymedical consulting servicepharmaceutical companynonclinical/clinical studyconsult serviceclinical pharmacologymedicine validationregulatory submission
* We use standard office opening hours in near Amador Bioscience's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Amador Bioscience is Laboratory Services (Healthcare) business from China that founded in 2018 (6 years old in 2024), Amador Bioscience business is focusing on Consulting Services.
Amador Bioscience headquarter office and corporate office address is located in Unit 504-506, Building 1, Singapore Science & Technology Park Jianggan District Hangzhou, Zhejiang China.
Amador Bioscience was founded in China.
In 2024, Amador Bioscience is currently focus on consulting services sector.
Above is snippet of Google Trends for "consulting services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Amador Bioscience, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.